HAEMONETICS CORP

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($26.3m) $45.6m $55.0m $76.5m $79.5m $43.4m $115.4m $117.6m $167.7m $97.3m
Depreciation and amortization $89.7m $89.2m $109.4m $110.3m $84.3m $97.7m $93.3m $97.2m $115.6m $111.7m
Depreciation $66.5m $57.7m $76.8m $76.6m $43.1m $44.4m $51.2m $55.8m $60.0m $61.2m
Amortization $27.1m $26.0m $24.8m ($25.7m) ($25.7m)
Amortization of Debt Issuance Costs $0 $0 ($13.5m) $3.4m $2.0m $3.2m ($23.1m) $0
Amortization of Intangible Assets $37.2m $31.9m $32.6m $34.2m $32.8m $56.6m $42.1m $41.4m $55.6m $50.5m
Capitalized Computer Software, Amortization $9.5m $4.4m $12.5m $8.4m $8.5m $8.6m $6.7m $6.1m
Deferred Income Tax Expense (Benefit) ($6.8m) ($5.8m) $13.4m ($6.7m) ($20.8m) $5.0m $5.8m ($10.9m) ($5.6m) ($26.4m)
Deferred Other Tax Expense (Benefit) ($6.8m) ($5.8m) $13.4m ($7.0m) ($19.9m) $5.0m $4.8m ($11.0m) ($5.2m) ($26.5m)
Share-based Payment Arrangement, Noncash Expense $9.2m $13.0m $17.2m $20.5m $25.5m $24.4m $25.6m $28.3m $29.6m $33.8m
Payment, Tax Withholding, Share-based Payment Arrangement $5.9m $10.2m $5.0m
Share-based Payment Arrangement, Expense $9.2m $13.0m $17.2m $20.5m $25.5m $24.4m $25.6m $28.3m $29.6m $33.8m
Gain (Loss) on Sale of Assets and Asset Impairment Charges $0
Goodwill and Intangible Asset Impairment $10.4m
Goodwill, Impairment Loss $57.0m $0 $0 $0 $0
Impairment of Intangible Assets, Finite-lived $4.8m $0 $0 $0 $0 $600k $607k $10.4m $2.4m $86.5m
Restructuring Costs and Asset Impairment Charges $51.2m $32.8m
Gain (Loss) on Disposition of Assets ($9.6m) ($382k) ($2.0m)
Gain (Loss) on Disposition of Business $9.6m
Gain (Loss) on Disposition of Property Plant Equipment $2.8m $2.8m $2.8m $16.8m $1.8m $2.0m $1.6m $1.8m $15.7m $714k
Income Tax Expense (Benefit) ($1.2m) $14.1m $18.6m $10.6m ($6.6m) $20.3m $26.0m $34.3m $44.4m $30.7m
Other Nonoperating Income (Expense) ($8.1m) ($4.5m) ($9.9m) ($16.2m) ($16.8m) ($17.1m) ($14.6m) ($13.0m) ($9.7m) ($28.7m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($3.2m) ($5.1m) $38.1m ($18.9m) ($44.1m) $35.0m $24.4m $24.2m ($7.0m) $14.9m
Increase (Decrease) in Inventories $1.6m ($14.4m) $39.3m $84.7m $38.9m ($24.3m) ($30.8m) $60.1m $64.7m ($47.4m)
Proceeds from Stock Options Exercised $29.4m $37.1m $10.2m $8.6m $6.2m $2.3m $2.6m $1.6m
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $8.0m $0 $0 $32.8m $9.6m $382k $2.0m
Foreign Currency Transaction Gain (Loss), before Tax ($1.8m) ($200k) ($2.3m) ($2.9m) ($700k) ($1.5m) ($1.0m) ($4.0m) ($900k) ($3.2m)
Gain (Loss) on Investments $0 $0 $0
Gain (Loss) Related to Litigation Settlement $1.4m $5.2m $6.7m
Goodwill $210.8m $211.4m $210.8m $210.7m $466.4m $467.3m $466.2m $565.1m $604.3m $656.4m
Operating Expenses $397.9m $355.8m $334.0m $381.2m $308.1m $424.8m $459.1m $526.7m $527.1m $630.9m
Restructuring Costs $14.1m
Revenue from Contract with Customer, Including Assessed Tax $967.6m $988.5m $870.5m $993.2m $1.2b $1.3b $1.4b $1.3b
Unrealized Gain (Loss) on Derivatives ($517k) $649k $24k ($813k) ($1.9m)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement ($289k) $184k $330k $0 $104k ($15k)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment $152k ($73k) ($209k) $0
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($4.6m) ($1.3m) $200k ($625k) ($6.9m)
Net Cash Provided by (Used in) Operating Activities $159.7m $220.3m $159.3m $158.2m $108.8m $172.3m $273.1m $181.8m $181.7m $293.2m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $76.1m $74.8m $119.0m $48.8m $37.0m $96.5m $110.2m $66.3m $39.3m $32.8m
Payments to Acquire Businesses, Net of Cash Acquired $2.9m $243.9m $150.9m $60.2m
Net Cash Provided by (Used in) Investing Activities ($73.3m) ($63.0m) ($116.1m) ($57.2m) ($425.4m) ($86.3m) ($143.8m) ($322.4m) ($161.9m) ($179.5m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $347.8m $0
Repayments of Long-term Debt $42.7m $61.7m $266.9m $13.1m $21.9m $17.5m $9.6m $12.2m $4.7m
Payments for Repurchase of Common Stock $0 $100.0m $160.0m $175.0m $0 $0 $75.0m $0 $225.0m $175.0m
Proceeds from (Payments for) Other Financing Activities $0 $0 ($99k) ($46k) ($5k) ($44k) ($73k) ($249k) ($102k)
Net Cash Provided by (Used in) Financing Activities ($60.4m) ($120.6m) ($50.6m) ($131.2m) $367.5m ($15.7m) ($100.4m) $38.2m $108.8m ($178.5m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($1.6m) $3.9m ($3.3m) ($1.9m) $4.2m ($3.0m) ($3.9m) ($3.2m) ($685k) $3.5m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($1.6m) $3.9m ($3.3m) ($32.0m) $55.0m $67.2m $25.0m ($105.7m) $128.0m ($61.3m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $137.3m $192.3m $259.5m $284.5m $178.8m $306.8m $245.4m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $7.8m $7.7m $13.1m $12.5m $7.8m $6.2m $13.6m $20.9m $16.5m $17.5m
Income Taxes Paid, Net $7.0m $9.1m $8.2m $11.5m $12.5m $24.3m $18.0m $52.7m $49.3m $60.7m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.